학술논문

Acquired resistance to the mutant-selective EGFR inhibitor AZD9291 is associated with increased dependence on RAS signaling in preclinical models
Document Type
Article
Source
In: Cancer Research. (Cancer Research, 15 June 2015, 75(12):2489-2500)
Subject
Language
English
ISSN
15387445
00085472